ATA-200 Gene Therapy Trial in Patients With LGMDR5
NCT05973630
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
4
Enrollment
INDUSTRY
Sponsor class
Conditions
LGMD2C
Interventions
BIOLOGICAL:
ATA-200
Sponsor
Atamyo Therapeutics